The United States District Court for the Southern District of Florida on January 13, 2009, entered final judgments, by consent, against Defendants University Health Industries Inc. ('ULT') and George Theodoropoulos, a/k/a George Theodore. The final judgments, under which Theodore and ULT neither admitted nor denied the allegations of the Commission's complaint, contain permanent injunctions enjoining both defendants from future violations of Sections 5(a) and (c) and 17(a) of the Securities Act of 1933 and Section 10(b) and Rule 10b-5 of the Securities Exchange Act of 1934. The final judgment against Theodore further orders: a 10-year officer-and-director bar; a penny stock bar; disgorgement of $422,577.93, representing his gains as a result of the conduct alleged in the complaint; prejudgment interest on disgorgement of $36,407.71; and a civil penalty of $60,000. The Commission dismissed its claims for disgorgement and a civil penalty against ULT, which is now in receivership, has ceased business operations, and has no assets.

University Health Industries Inc. announced that it is launching a new pet health care division. The pet health care division is designed to expand University Health Industries' current market focus on human health into the pet health care market. The lead product will be a pet formulated version of University Health Industries popular and successful Arthroleve(TM) product for joint health and arthritis, which will be designed with a dosage and delivery system specific to canines.

Virtual Innovations Inc., changed its name to University Health Industries Inc.